Progenics Pharmaceuticals, Inc. (PGNX) Misses Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts PGNX Hot Sheet
Price: $4.10 --0%
Financial Fact:
General and administrative: 7.22M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
General and administrative: 7.22M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) reported Q3 EPS of ($0.33), $0.03 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $1.12 million versus the consensus estimate of $2.51 million.
For earnings history and earnings-related data on Progenics Pharmaceuticals, Inc. (PGNX) click here.
For earnings history and earnings-related data on Progenics Pharmaceuticals, Inc. (PGNX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Ideal Power (IPWR) Tops Q2 EPS by 2c
- MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
